Table 4.
Agreement between actual prescribing of ICS/LABA for 59 COPD patients (FEV 1 /FVC < 0.7) with no concomitant diagnosis of asthma in 2009/10 and the prescribing recommended based on the 2011 GOLD guidelines
| ICS/LABA recommended (FEV 1 % predicted < 50 or previous exacerbation) | |||
|---|---|---|---|
| ICS/LABA |
Yes |
No |
|
| prescribed 2009/10 |
|
|
|
| Yes |
14 |
9 |
23 |
| No |
17 |
19 |
36 |
| |
31a |
28 |
59 |
| Kappa = 0.13 (SE 0.12) | |||
aFrequent exacerbation only was recorded in eight patients, predicted FEV1% <50% only in 12 patients, and both findings in 11 patients.